Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-03-30

Clinical Trial Update: CMV CTLs in Neonates With CMV Infection [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating CMV-specific cytotoxic T lymphocytes (CMV CTLs) in neonates with congenital CMV infection, curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CMV CTLs (CMV-specific cytotoxic T lymphocytes)

Snippet

Sponsor: New York Medical College | Conditions: Congenital Cytomegaloviral (CMV) Disease | Phase 2 | Status: RECRUITING